Author:
Billard Etienne,Létourneau Myriam,Hébert Terence E.,Chatenet David
Funder
Natural Sciences and Engineering Research Council of Canada
Canadian Institutes of Health Research
Subject
Pharmacology,Biochemistry
Reference47 articles.
1. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease;Douglas;Trends Cardiovasc. Med.,2000
2. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey;Douglas;Br. J. Pharmacol.,2000
3. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14;Ames;Nature,1999
4. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function;Vaudry;Pharmacol. Rev.,2015
5. The urotensin II system and carotid atherosclerosis: a role in vascular calcification;Albanese;Front. Pharmacol.,2016
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献